TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded October 23, 2009